References: | Cheng, J. C., Matsen, C. B., Gonzales, F. A., Ye, W., Greer, S., Marquez, V. E., ... & Selker, E. U. (2003). Inhibition of DNA methylation and reactivation of silenced genes by zebularine.Journal of the National Cancer Institute,95(5), 399-409. Zhou, L., Cheng, X., Connolly, B. A., Dickman, M. J., Hurd, P. J., & Hornby, D. P. (2002). Zebularine: a novel DNA methylation inhibitor that forms a covalent complex with DNA methyltransferases.Journal of molecular biology,321(4), 591-599. Addison, M. K., Coley, L. W., Gentry, G. T., Godke, R. A., & Bondioli, K. R. (2011). 209 epigenetic modification with zebularine and valproic acid and expression of pluripotency genes in bovine adipose stem cells.Reproduction, Fertility and Development,24(1), 216-217. Naeem, N., Haneef, K., Kabir, N., Iqbal, H., Jamall, S., & Salim, A. (2013). DNA Methylation Inhibitors, 5‐azacytidine and Zebularine Potentiate the Transdifferentiation of Rat Bone Marrow Mesenchymal Stem Cells into Cardiomyocytes.Cardiovascular therapeutics,31(4), 201-209. |